Overview
Status
Active
Registry date
2019-09-02
Share capital
50 000,00 PLN
Registered address
ul. Iłowska 14A, 61-311 Poznań, Poland
Industry
- Manufacture of other chemical products (20.5)
Authorized Representatives
Anna Ziemnicka – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Damian Szpryncage 42 | 50 | $13,506.21 | 100% |
Beneficial owners
No beneficial owners recorded for the company Biotechnic Group.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 10, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,904$1,904 | Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-11 | Address change (Rynek Główny 28, 31-010, Kraków → Ul. Iłowska 14a, 61-311, Poznań) | |
| 2019-09-02 | Entered in the register |
FAQ
The main business activity of Biotechnic Group focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on September 2, 2019.
The headquarters is located at: ul. Iłowska 14A, 61-311 Poznań.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-10-07